Equilibrium between host and cancer caused by effector T cells killing tumor stroma
- PMID: 18316622
- DOI: 10.1158/0008-5472.CAN-07-5324
Equilibrium between host and cancer caused by effector T cells killing tumor stroma
Abstract
The growth of solid tumors depends on tumor stroma. A single adoptive transfer of CD8(+) CTLs that recognize tumor antigen-loaded stromal cells, but not the cancer cells because of MHC restriction, caused long-term inhibition of tumor growth. T cells persisted and continuously destroyed CD11b(+) myeloid-derived, F4/80(+) or Gr1(+) stromal cells during homeostasis between host and cancer. Using high-affinity T-cell receptor tetramers, we found that both subpopulations of stromal cells captured tumor antigen from surrounding cancer cells. Epitopes on the captured antigen made these cells targets for antigen-specific T cells. These myeloid stromal cells are immunosuppressive, proangiogenic, and phagocytic. Elimination of these myeloid cells allowed T cells to remain active, prevented neovascularization, and prevented tumor resorption so that tumor size remained stationary. These findings show the effectiveness of adoptive CTL therapy directed against tumor stroma and open a new avenue for cancer treatments.
Similar articles
-
Targeting the stroma by T cells to limit tumor growth.Cancer Res. 2008 Dec 1;68(23):9570-3. doi: 10.1158/0008-5472.CAN-08-2414. Cancer Res. 2008. PMID: 19047130 Review.
-
Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.Prostate. 2009 Jun 15;69(9):938-48. doi: 10.1002/pros.20942. Prostate. 2009. PMID: 19267351
-
The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.Eur J Immunol. 2009 Aug;39(8):2259-69. doi: 10.1002/eji.200939341. Eur J Immunol. 2009. PMID: 19637198
-
Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.Cancer Res. 2008 Apr 15;68(8):2993-3000. doi: 10.1158/0008-5472.CAN-07-5008. Cancer Res. 2008. PMID: 18413769
-
The role of tumor stroma in the interaction between tumor and immune system.Curr Opin Immunol. 2005 Apr;17(2):180-6. doi: 10.1016/j.coi.2005.01.008. Curr Opin Immunol. 2005. PMID: 15766679 Review.
Cited by
-
MicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cells.Sci Rep. 2016 Aug 3;6:30923. doi: 10.1038/srep30923. Sci Rep. 2016. PMID: 27484289 Free PMC article.
-
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells.J Exp Med. 2011 Sep 26;208(10):2005-16. doi: 10.1084/jem.20101159. Epub 2011 Sep 19. J Exp Med. 2011. PMID: 21930765 Free PMC article.
-
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.J Clin Invest. 2011 Dec;121(12):4746-57. doi: 10.1172/JCI58814. Epub 2011 Nov 7. J Clin Invest. 2011. PMID: 22056381 Free PMC article.
-
Potential targets for pancreatic cancer immunotherapeutics.Immunotherapy. 2011 Apr;3(4):517-37. doi: 10.2217/imt.11.10. Immunotherapy. 2011. PMID: 21463193 Free PMC article. Review.
-
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.Cancer Immunol Res. 2017 Feb;5(2):127-136. doi: 10.1158/2326-6066.CIR-16-0293. Epub 2017 Jan 11. Cancer Immunol Res. 2017. PMID: 28077434 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials